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Abstract: p-Cresyl sulfate is one of the bound uremic toxins whose level increases in the sera of
patients with the severity of chronic kidney disease and is therefore used as a standard for clinical
investigations. Our first attempts to obtain p-cresyl sulfate led exclusively to the product of sulfonation
of the aromatic ring instead of sulfation on the OH moiety. Nevertheless, this initial discouraging result
allowed us to handle both p-cresyl sulfate and 2-hydroxy-5-methylbenzenesulfonic acid obtained
by different synthetic pathways. Interestingly, the comparison between the two isomers pointed
out that the two molecules show the same fragmentation pattern and are indistinguishable by mass
spectrometry. They cannot be separated on several commercially available columns. The only
difference between the two compounds is a 10-fold higher ionization yield under negative ion
electrospray ionization. NMR spectral studies definitely confirmed the different molecular structures.
We present here an unambiguous biomimetic synthetic route for p-cresyl sulfate and the spectroscopic
characterization of both the compounds by nuclear magnetic resonance and mass spectrometry.
Keywords: p-cresyl sulfate; chronic kidney disease (CKD); urine; mass spectrometry; HPLC; bioanalysis
1. Introduction
The aryl sulfates, p-cresyl sulfate (pCS) and indoxyl sulfate (IxS), are protein-bound uremic toxins
(UTx), the levels of which increase in the sera of patients with the severity of chronic kidney disease
(CKD), and both have been shown to have a strong negative correlation with renal function (estimated
glomerular filtration rate (eGFR)) [1–4]. Toxicity of pCS has been associated with a number of clinical
conditions [5] that show an increase in pCS, such as children autism [6] and heart diseases [7].
p-Cresol is both a minor biotransformation product of toluene, a volatile organic compound
(VOC) present in urban atmosphere and an industrial solvent, and a metabolite of anaerobic
bacteria that biotransform the amino acids tyrosine and phenylalanine [8]. According to current
knowledge, Clostridium difficile, a major cause of diarrhea, is one of the main producers of pCS in the
human gut [9]. At the molecular scale, the key process of an enzymatic multistage mechanism is
degradation of p-hydroxyphenyl-2-keto-propionic acid, the Tyr transamination catabolite, to pCS by
4-hydroxyphenylacetate decarboxylase (EC 4.1.1.83), an [FeS] enzyme [5], whose active site entails the
presence of a glycyl radical enzyme [10]. Another pathway may entail p-hydroxyphenylpyruvic acid
as the direct precursor of p-cresol, through the action of another glycyl radical enzyme [11].
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In humans, hepatic phase II biotransformation converts the phenolic products into their
glucuronide and sulfate end products for urinary elimination [12–14] (Figure 1). Due to their
strong binding to plasma proteins, both pCS and IxS cannot be removed efficiently by hemodialysis
(HD) or peritoneal dialysis (PD) [15] and accumulate, thus their measurement in plasma can be used
to monitor the extent of organ damage in CKD patients undergoing HD or PD and awaiting kidney
transplantation. Although analytical methods that employ pre-column and liquid chromatography
with fluorescence detection have been developed to establish reference ranges of IxS and pCS [16],
a reliable analytical method employing mass spectrometry needs the availability of authenticated pure
standards and of isotope-labeled internal standards for robust quantification [16].
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Figure 1. Graphical overview of biochemical transformation of tyrosine coming from food proteins and
cellular exfoliation in gut by Clostridium difficile. Through portal circulation, p-cresol reaches the liver
where it is bio-transformed by sulfotransferase into p-cresyl sulfate. In healthy persons, more than 99%
of pCS is bound to albumin, thus excretion through the kidney occurs primarily via tubular secretion
by an organic anion transport system. This binding is decreased in uremic patients.
When we started this work, pCS was hardly commercially available, so we decided to prepare and
characterize authentic specimens for method set-up and validation. Synthetic approaches were tested;
however, the results were different from those anticipated from the literature [16–23]. The necessity
of unambiguous product characterization and reliable route for pCS sample preparation highlighted
some novel facets of thi deceivingly simple molecule.
2. Results and Discussion
2.1. Compound Preparation
During our studies of simultaneous quantification of the UTx compounds, pCS and IxS, we needed
to synthetize authentic pCS in its natural abundance and isotopically labeled forms.
For the sy thesis of pCS (1), we started from the method [23] used by a number of authors [16–22].
Unfortunately, in our hand, this procedure [21,23] led exclusively to the sulfonation of the aromatic
ring (2) instead of sulfation on the OH moiety (1).
The elucidation of real structure of the obtained compound was achieved by a careful study
of 1H-NMR and 13C-NMR spectra (Section 2.2) that let us to conclude that the compound was
2-hydroxy-5-methylbenzenesulfonic acid (2) rather than pCS (1). To our knowledge, a detailed
description of NMR spectra of 1 and 2 has not been reported yet and for this reason, we thought it
useful to underline this topic.
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A careful analysis of the literature [24–29] shows how obtaining the sulfation product
could be a challenging target, due to the concurrent formation of the sulfonation product.
In particular, Cerfontain and Koeberg-Telder [28] reported a detailed study of the sulfonation of
4-methylphenol in H2SO4 ranging in concentration from 81.6–112.2% and noted that the 2- to 3-sulfonic
acid ratio increases strongly upon increasing the H2SO4 concentration. The 1H-NMR spectrum is
also reported.
The first attempts made by us in accordance with literature [23,30] with chlorosulfonic acid as
the source of sulfate and dimethyl aniline or pyridine as the in-situ base and leaving group, gave the
exclusive formation of the sulfonated product (2) (Figure 2), by reaction at the ortho-ring carbon atom.
Changing the sequence of reagents, the reaction temperature, and the base did not give the expected
result [31]. Direct sulfation with sulfuric acid at different concentrations gave only the sulfonation
product (2).
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Figure 2. Structure of reaction products of activated sulfuric acid at the oxygen atom (sulfation, 1), at a
ring carbon atom (sulfonation, 2).
After a careful investigation about the reaction conditions, we managed to obtain target compound
1, only through a condensation procedure with dicyclohexylcarbodiimide (DCC). This improved
procedure is serendipitously biomimetic, since it entails the use of an activated, electrophilic form
of sulfuric acid, in principle analogous to 3′-phosphoadenosine-5′-phosphosulfate, which is the
active cofactor of sulfokinases (SULT), the enzymes responsible for sulfate transfer to phenolic an
alco ol-bearing phase I biotransformation products of endogenous and xen biotic substrates [32].
This may explain the success of the condensation method in avoiding the concomitant formation of
sulfonic acid, which is the only product when sulfuric acid or chlorosulfonic acid are employed.
2.2. Compound Characterization
2.2.1. NMR Analysis
Th st uctural assignment of the products were made by 1H-NMR spectroscopy and were based
on the relative area r tios of th peaks, the multiplicity of various sign s, the coupling constants,
and the specific substituent shi lding parameters [33,34].
Figures 3 and 4 show the 1H-NMR and the 13C-NMR spectra, respectively, of pCS (1, top) and
2-hydroxy-5-methylbenzenesulfonic acid (2, bottom). The important differences in the spectra allow
unequivocal identification of the individual isomers, either after purification or directly in a reaction
mixture. In the 1H-NMR spectrum of compound 2 initially obtained, there are three different kinds
of hydrogens on the aromatic ring at 7.47, 7.13, and 6.78 ppm instead of the expected two. In pCS to
a simple first order approximation, the appearance of the signals for all four 1H-atoms are readily
predictable. The H-2 and H-6 are equivalent and so produce one chemical shift just like the H-3 and
H-5 at 6.71 and 7.03 ppm, respectively.
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The same applies to 13C-NMR spectrum showing six different peaks, three substituted aromatic
carbon atoms at 133.8, 127.9, and 121.4 ppm, and three unsubstituted carbon atoms at 162.1, 129.0,
and 121.8 ppm, thereby demonstrating that in the obtained compound there are six different carbon
environments at 162.1, 133.8, 129.0, 127.9, 121.8, and 121.4 ppm. Instead, in pCS (1), there are four
different carbon environments and four different peaks. These considerations got us thinking that,
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in our hands, applying the method reported by Feigenbaum et al. [23], the sulfonation (reaction at a
ring carbon atom) took place instead of sulfation (reaction at the oxygen atom).
2.2.2. Mass Spectrometry
Characterization and differentiation of the isomers 1 and 2 by mass spectrometry proved much
more challenging, in an unexpected way. Our negative ion ESI-MS/MS spectra of NMR-characterized
pCS (1) are comparable to that reported by Attygalle et al. [35] for the lower homolog phenyl sulfate
and show the expected fragmentation channels (Supplemental Material, Figure S1).
Essentially the same expected reaction pathways occur for the two compounds, with the only
difference of the ratio of the main ion signals (Figure 5). The fragmentation pathways are those
expected, and entail generation of deprotonated p-cresol (m/z 107) and of electron-attached sulfur
trioxide (SO3−; m/z 80 for 32S, 82 for 34S).
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In pCS (1), a weak, yet intriguing transition leads to oxygen insertion and formation of deprotonated
4-methyl-1,2-dihydroxy-benzene (m/z 123), the connectivity of which is supported by observation of
H loss to yield the radical anion of 4-methyl-o-quinone (m/z 122). One main objective of our extensive
characterization by mass spectrometry of the isomers 1 and 2 is to try to discriminate the two possible
connectivities, i.e., the phenyl sulfate from the aryl sulfonic acid. As apparent from the pair of displayed
integrated fragment spectra (Figure 5), identical fragmentation is obtained for the two isomers.
In addition, unimolecular decomposition of the deprotonated molecule (m/z 187) of
both compounds yields almost superimposable breakdown curves of the main fragment ions
(Supplemental Material, Figure S2). A detailed discussion of the fragmentation processes of the
two compounds is reported as Supplemental Material (Figure S3) and references therein.
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2.3. Studies for Separation of pCS (1) and 2-Hydroxy-5-Methylbenzenesulfonic Acid (2) by LC-MS/MS
The optimization of analysis conditions was undertaken in order to ensure a reliable separation of
pCS (1) and 2-hydroxy-5-methylbenzenesulfonic acid (2). Several column phases were tested such as
C18, C18-amide, C18-polar, ether-linked, and hydrophilic interaction liquid chromatography. None of
them provided the desired separation, and neither did pentafluorophenyl phase coupled to the use of
ammonium buffer and 0.01% of formic acid, which instead allowed a baseline separation of pCS and IxS
(data not shown). The only difference showed between pCS (1) and 2-hydroxy-5-methylbenzenesulfonic
acid (2) was the intensity displayed when they were injected at the same concentration: singularly 2
was 10-fold-higher than 1 (Figure 6).
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3. aterial and ethods
3.1. Chemistry
Chemicals, solvents, and standards were obtained from Sigma-Aldrich and used without further
purification. The progress of the reactions was monitored by analytical thin-layer chromatography
(TLC) on pre-coated glass plates (silica gel 60 F254-plate-Merck, Darmstadt, Germany) and the
products were visualized by UV light. Purity of all compounds (>99%) was verified by thin-layer
chromatography and NMR measurements [36,37].
3.2. Synthesis of p-Cresyl Sulfate (1)
DCC (4 g, 21 mmol) in dichloromethane anhydrous was added to a cold solution of p-cresol
(1.5 g, 14 mmol) in dichloromethane anhydrous. After 20 min under stirring at 0 ◦C, concentrated
sulfuric acid (800 µL, 14 mmol) was slowly added and stirring continued for 2 h at room temperature.
The reaction was monitored by TLC (CH2Cl2/MeOH 95:5, v/v). NaOH was added and the precipitate
was filtered under vacuum, washed with dichloromethane, solubilized in methanol, and concentrated.
Cold diethyl ether was added giving a white precipitate corresponding to the desired product as
sodium salt (1 g, 4.8 mmol, 34%). The title compound was obtained by treatment with acid under
mild conditions: 210 mg (1 mmol) of the sodium salt was dispersed in methanol (2 mL) under stirring,
then an acidic resin (10% w/w; Dowex 50WX8-200) was added. When the compound was completely
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dissolved (1 h), the product was recovered by filtration under vacuum and subsequent evaporation of
the solvent (yield >98%); mp. 250 ◦C (sample turns to brown), 284 ◦C (decomposition).
3.3. 2-Hydroxy-5-methylbenzenesulfonic Acid (2) Formation
3.3.1. General Procedure
1.2 g of chlorosulfonic acid (10 mmol) were added dropwise with constant stirring to an ice-cooled
solution of 1g of p-cresol (9.25 mmol) in 10 mL of pyridine. After 1 h, NaOH was added and the
precipitate was recovered by filtration under vacuum. The solid was solubilized in methanol and
reprecipitated with cold diethyl ether giving the sodium salt of compound 2 as a white solid 1.6 g
(8.32 mmol, 90%). The same reaction was also performed at −78 ◦C. The title compound was obtained
by treatment with acid under mild conditions.
3.3.2. 2-Hydroxy-5-methylbenzenesulfonic Acid (2) Formation Using Different Bases
1.2 g of chlorosulfonic acid (10 mmol) was added dropwise with constant stirring to an ice-cooled
solution of 1 g of p-cresol (9.25 mmol) and a base (18.5 mmol; pyridine 1.5 mL or triethylamine 2.6 mL,
or 2,6-lutidine 2.2 mL) in 10 mL of dichloromethane anhydrous. After 1 h, NaOH was added and
the precipitate was recovered by filtration under vacuum. The solid was solubilized in methanol
and reprecipitated with cold diethyl ether giving the sodium salt of compound 2 as a white solid
(7.86–8.50 mmol, 85–92%). The same reactions were performed by adding the reagents in the following
order: chlorosulfonic acid, base, and p-cresol. The title compound was obtained by treatment with acid
under mild conditions.
3.4. NMR Analysis
NMR spectra were registered on a Bruker AVANCE 500 spectrometer equipped with a 5-mm
broadband reverse probe and deuterium lock with field z-gradient operating at 500.13 and 125.76 MHz
for 1H and 13C, respectively from 40 mM solutions (20 mmol of product dissolved in 0.5 mL of
solvent). All NMR spectra were recorded at 298 K in D2O (isotopic enrichment 99.98%) solution
and the chemical shifts were reported on a δ (ppm) scale. The proton spectra calibration of the
chemical shift scale was performed by adjusting the residual H2O signals to 4.70 ppm (298 K, 40 mM,
pH = 7.0). The chemical shifts of the carbon spectra in D2O were referenced to external TSP-d4
(3-(trimethylsilyl)-propionic-2,2,3,3-d4 acid sodium salt) at 0.00 ppm. Acquisition parameters for 1D
were as follows: 1H spectral width of 5000 Hz and 32 K data points providing a digital resolution of ca.
0.305 Hz per point, relaxation delay 2 s; 13C spectral width of 29412 Hz and 64 K data points providing
a digital resolution of ca. 0.898 Hz per point, relaxation delay 2.5 s. The experimental error in the
measured 1H-1H coupling constants was ±0.5 Hz.
3.4.1. p-Cresyl Sulfate (pCS, 1)
1H-NMR (D2O) δ: 7.03 (2H, d, J = 8.4 Hz, 3-H, 5-H), 6.71 (2H, d, J = 8.4 Hz, 2-H, 6-H), 2.14 (3H, s,
CH3); 13C-NMR δ: 153.0 (C-1), 130.3 (C-3, C-5), 130.8 (C-4), 115.3 (C-2, C-6), 19.5 (CH3).
3.4.2. 2-Hydroxy-5-methylbenzenesulfonic Acid (2)
1H-NMR (D2O) δ: 7.16 (1H, d, J = 2.4 Hz, 6-H), 6.82 (1H, dd, J = 2.4, 8.3 Hz, 4-H), 6.47 (1H, d, J =
8.3 Hz, 3-H), 2.28 (3H, s, CH3); 13C-NMR δ: 162.1 (C-2), 133.8 (C-4), 129.0 (C-5), 127.9 (C-6), 121.8 (C-1),
121.4 (C-3), 19.3 (CH3); mp. 250 ◦C.
3.5. Mass Spectrometry
All mass spectrometric measurements were performed in an AB Sciex 3200 QTRAP instrument with
own electrospray ion source and proprietary software, and operated according to the manufacturer’s
instructions. Measurements were performed either by infusion with the 1-mL instrument’s syringe
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pump (flow of 5 or 10 µL/min). For infusion, usually solutions of the compound at a final concentration
of 1–10 ng/mL were used.
Source spectra were scanned in the negative ion mode between m/z 100 and 600, at a scan
speed of 2 s per spectrum, in the multichannel analysis (MCA) mode, as the sum of 25 individual,
consecutive scans.
Fragment ion spectra were recorded in the negative ion mode both in the conventional Q3-filter
mode and in the Q3-trap (enhanced parent ion, EPI) mode. Recording started from m/z 50 to
approximately 5 m/z higher than that of the precursor ion. Collision-induced dissociation was achieved
with nitrogen, at the gas low pressure setting (approximately 2.5 × 10−5 Torr, with 0.8 × 10−5 Torr being
the background gas pressure). In the conventional Q3-filter mode, a scan speed of 5 s per spectrum
was employed. In the Q3-trap (enhanced parent ion, EPI) mode, scan speed was set at the slowest
value of 250 amu/s, that which yields the best ion resolution. Integrated fragment ion spectra were
recorded in both Q3 scan modes, using the ramp parameter. Briefly, one fragment ion spectrum was
obtained at each value of the collision potential (CP) in an interval starting from 0 ∆V and up to 70 ∆V
in 0.5- or 1-V increments. The data file was thus composed of a number of individual Q3 scans equal to
the number of voltage steps of the ramp parameter function. From this data file, the ion current of each
ion was extracted with the XIC command of the analyst software, and exported as a separate .txt file,
that was imported in a Microsoft Excel spreadsheet for post-acquisition data elaboration.
All displayed measurements are obtained by post-acquisition data elaboration in a Microsoft
Excel spreadsheet, essentially following literature [38–40], to measure integrated intensities of ions
and their thermodynamic parameters such as appearance energies of fragments from the respective
breakdown curves.
3.6. LC-MS/MS Conditions
Separation of synthesized pCS (1), 2-hydroxy-5-methylbenzenesulfonic acid (2), and standard
IxS was carried out on HPLC Dionex 3000 UltiMate system (Thermo Fisher Scientific, MA, USA)
coupled to the tandem mass spectrometer AB Sciex 3200 QTRAP (AB Sciex, Milan, Italy) operating
under ESI ionization and in the negative ion mode. The instrument parameters were: CUR 30, GS1
40, GS2 50, capillary voltage −4.5 kV, and source temperature 550 ◦C. The three compounds were
analyzed by selected reaction monitoring (SRM) checking the transitions: m/z 187.1 > 80 (−36 eV),
187.1 > 107 (−32 eV) for both pCS (1) and 2-hydroxy-5-methylbenzenesulfonic acid (2), whereas m/z
212.0 > 80 (−30 eV) and 212.0 > 132.1 (−26 eV) for IxS. The declustering potential was fixed to −40 ∆V.
Chromatographic separation was achieved on an Accucore PFP 2.1 × 100 mm 2.6 µm (Thermo Fisher
Scientific, MA, USA) using as mobile phase (A) 5 mM ammonium formate + 0.01% formic acid and (B)
acetonitrile. The flow rate was 250 µL/min, and the column and the autosampler were held at 30 ◦C
and 15 ◦C, respectively. The gradient elution was the following: 0–1 min 10% (B), 1–3.5 min 10–50%
(B), 3.5–5.5 min 50% (B), and 5.5–6 min 50–10% (B) held until 8 min. Retention times were 2.7 min for
both pCS (1) and 2-hydroxy-5-methylbenzenesulfonic acid (2) and 3.0 min for IxS.
4. Conclusions
This study starts from the awareness, given by NMR spectra, that initial synthetic approaches
unexpectedly produced only 2-hydroxy-5-methylbenzenesulfonic acid (2), instead of the desired pCS
(1) obtained following a different synthetic pathway. Possibly slight modifications of experimental
procedure, gave one compound rather than the other. 1H and 13C magnetic resonance spectroscopy can
distinguish the different molecular structures, since this technique is strongly sensitive to symmetry in
the molecular connectivity. Interestingly the possibility to compare the two isomers 1 and 2 allowed
us to realize that the two molecules are indistinguishable by mass spectrometry. Mass spectrometry
even performed with the mildest ionization technique highlighted an unexpected loss of specific
molecular connectivity in the formed ions because 1 and 2 show the same fragmentation pattern and in
addition cannot be separated on several commercially available columns. The only difference between
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the two compounds is a 10-fold higher ionization yield under negative ion electrospray ionization.
These considerations could be useful to avoid mistaking the compounds, bearing in mind that pCS
(1), the protein-bound uremic retention solute, shall be considered in the sera of patients with chronic
kidney disease rather than 2-hydroxy-5-methylbenzenesulfonic acid (2), that is not a human metabolite.
The observation that the ionization sensitivity of the two constitutional isomers 1 and 2 is different
by a full order of magnitude could have consequences when levels of pCS are measured in clinical
studies. The wrong isomer is much more ionization-prone that the natural metabolite, so if it is
used to prepare analytical standards, measured levels are deceivingly much lower than the real ones,
thus making mass balance unreliable.
Supplementary Materials: The following are available online at http://www.mdpi.com/1420-3049/24/20/3704/s1,
Figure S1. A: negative-ion fragment spectrum of pCS re-elaborated from Attygalle et al., 2001; center-of-mass
collision energy 4.88 eV), B: Fragment spectrum of pCS (our measurement, center-of-mass collision energy 4.88 eV).
Figure S2. Breakdown curves of the main ion species of pCS (1; A) and 2-hydroxy-4-methyl-phenylsulfonic acid
(2; B). Figure S3. Possible mechanisms for the formation of the observed fragment ions in the spectra of: A) pCS (1)
and B) 2-hydroxy-4-methyl-phenylsulfonic acid (2). Three further articles are cited as accompanying references.
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